Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Attempts to patent inappropriate innovations in the country have met with opposition. In May 2006, drug major Glaxo filed a patent application in Kolkata for <font class="UCASE">hiv </font> drug Combivir, which was a combination of Lamivudine and Zidovudine. The company withdrew the application following opposition from human rights organisations like the Indian Network for people living with <font class="UCASE">HIV/AIDS</font> and the Manipur Network of Positive People. <br>
the verdict on the long-drawn Novartis case over the patent on the drug Gleevic, the Madras High Court has upheld the Indian Patent Act
microsoft has accused Linux of patent violations. On may 14, 2007, Brad Smith, general counsel for Microsoft, told Fortune magazine that Linux, the open source operating system and other related
There is a logic to the idea of neglected diseases. Historically the diseases poor people get largely in the poorer parts of the world haven t got enough attention from policy makers in national governments and multilateral agencies precisely because they
<b><font class="UCASE">ranbaxy in norway:</font></b> The Norwegian Appeals Court ruled that Ranbaxy Laboratories Ltd's generic version of Lipitor did not infringe Pfizer Inc's patents. Ranbaxy says they will now be able to market their products in Norway. Pfizer markets its cholesterol-lowering drug Atorvastatin as Lipitor.
contamination of groundwater by arsenic, a well-known phenomenon, has now shown up in a different form. Scientists working in the Bengal delta have found that rice grown with or boiled in
Norway has urged the Swiss pharma major Novartis to withdraw its patents case against India (see
Indian drug manufacturer Ranbaxy is contesting us multinational Pfizer in 17 countries. It is filing for the right to manufacture generic versions of the world's bestselling drug Lipitor and a
thailand's capital Bangkok witnessed protests outside the office of us multinational Abbott Laboratories on March 14, 2007. A day before, the company had withdrawn applications to register seven new
The Ranbaxy-Pfizer dispute involves three drugs:Lipitor, Caduet and Norvasc. The last named is a blood pressure drug. Pfizer's patent over it was annulled recently ending a lucrative monopoly: